In today’s briefing:
- JD.com Inc (9618 HK) – Prominent ST Momentum Failures – Target Tactical 9-18% Rise
- Hong Kong CEO & Director Dealings (13 Apr): Melco, CMGE, Differ, Sino Biopharmaceutical
- Fushan Energy: Coking Coal Weak But 14% Yield and 55% of the Mkt Cap in Cash
- Guoquan Food (Shanghai) Pre-IPO Tearsheet
- Morning Views Asia: Meituan, Nickel Industries Ltd, Vedanta Resources
- [JD.com (JD US, SELL, TP US$27) Earnings Preview]: Slow-Growth and Competitive Pressure Remain
- [Luckin Coffee Inc. (LKNCY US) TP Change]: Strong New Product Sales Driving Seasonality Rebound
- Adicon Holdings Pre-IPO – Thoughts on Valuation
JD.com Inc (9618 HK) – Prominent ST Momentum Failures – Target Tactical 9-18% Rise
- JD.com Inc (9618 HK) has declined heavily in 2023 (-44.5%), producing a new 5 month low of 143.50 on 13 April 2023.
- The 143.50 low was plagued by extreme ST momentum failure and the new low was quick to fail and reverse.
- Our TSS methodology triggered a TSS < 10 at the low and justifies a further 9-18% upswing in the coming 1-2 weeks.
Hong Kong CEO & Director Dealings (13 Apr): Melco, CMGE, Differ, Sino Biopharmaceutical
- The data in this insight is collated from the “shareholding disclosure” link on the HKEx website.
- Often there is a corresponding HKEx announcement on the increase – or decrease – in the shareholding by directors. Or pledging. However, such disclosures are by no means an absolute.
- Stocks mentioned in this insight include: Melco International Development (200 HK), CMGE Tech (302 HK), Differ Group Auto (6878 HK), and Sino Biopharmaceutical (1177 HK)
Fushan Energy: Coking Coal Weak But 14% Yield and 55% of the Mkt Cap in Cash
- After declaring a whopping 18% dividend yield in FY22, we expect Shougang Fushan Resources (639 HK)’s generous payments to continue as they could declare another 14% in FY23e.
- The margin of safety is high as there is a cash buffer (55% of the market cap in cash) and 10-year average annual free cash flows of 1.5 bn HKD.
- China’s FAI stimulus and stabilizing the steel margins could be catalysts to drive the share price forward in the short term.
Guoquan Food (Shanghai) Pre-IPO Tearsheet
- Guoquan Food (Shanghai) (1786512D CH) is looking to raise about US$500m in its upcoming Hong Kong IPO.
- Guoquan Food (Shanghai) is a home meal solutions provider in China.
- Offering a wide variety of home meal solutions products under its Guoquan Shihui (鍋圈食匯) brand, the firm had a total of 755 SKUs as of Dec 22.
Morning Views Asia: Meituan, Nickel Industries Ltd, Vedanta Resources
Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.
[JD.com (JD US, SELL, TP US$27) Earnings Preview]: Slow-Growth and Competitive Pressure Remain
- We expect JD to report C1Q23 top-line and non-IFRS net income (1.7%) and (12%) vs. consensus, respectively.
- We expect revenue to decline (1%) YoY in 1Q23 and grow just 3% YoY in FY23, due to (1) slow recovery in key product categories like electronics; (2) team restructuring;
- And (3) competitive landscape. We maintain SELL and US$27 TP. Our TP implies 10x 2024 P/E.
[Luckin Coffee Inc. (LKNCY US) TP Change]: Strong New Product Sales Driving Seasonality Rebound
- We expect Luckin to report 1Q23 revenue at 77.0% YoY to RMB4,257mn, non-GAAP operating margin and net margin are expected to increase 12.6ppt and 9.1ppt to 16.4% and 13.2%;
- We think the current moderate competition can bring positive externality to coffee players, whereas it may hurt street tea shops;
- We maintain the stock as BUY and raise TP by US$1 to US$41.
Adicon Holdings Pre-IPO – Thoughts on Valuation
- ADICON Holdings Limited (ADI HK) is looking to raise about US$400m in its upcoming HK IPO.
- Adicon Holdings is one of the top three independent clinical laboratory (ICL) service providers in China in terms of total revenue during the Track Record Period, according to F&S.
- In this note, we talk about our thoughts on valuation.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars